Sartorius is a trusted international partner of the biopharmaceutical industry. The Sartorius Advanced Therapies Unit is focused on enabling cell therapy developers to bring therapies to market faster and make them more affordable. With our specialized scientific expertise, technical know-how, and unique knowledge of the cell therapy market, we offer compelling workflow solutions consisting of single-use consumables, analytical instruments, equipment, media, and services to accelerate time-to-market and lower COGs. These solutions are specifically designed to address the unique challenges and goals of R&D, process development and manufacturing. www.sartorius.com
The Alliance for Regenerative Medicine (ARM) is the leading international advocacy organization dedicated to realizing the promise of regenerative medicines and advanced therapies. ARM promotes legislative, regulatory, manufacturing and reimbursement initiatives to advance this innovative and transformative sector, which includes cell therapies, gene therapies and tissue-based therapies. Early products to market have demonstrated profound, durable and potentially curative benefits that are already helping thousands of patients worldwide, many of whom have no other viable treatment options. Hundreds of additional product candidates contribute to a robust pipeline of potentially life-changing regenerative medicines and advanced therapies. In its 12-year history, ARM has become the voice of the sector, representing the interests of 400+ members worldwide, including small and large companies, academic research institutions, major medical centers and patient groups. To learn more about ARM or to become a member, visit www.alliancerm.org.